Gynecologic Disease
Conditions
Brief summary
The purpose of this study is to evaluate the efficacy and safety of Mediclore®, as an antiadhesive barrier, which is made of Poloxamer, Gelatin and Chitosan.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients with Gynecological disease (benign disease) * Patients who Written informed consent * Patients without clinically significant lab
Exclusion criteria
* having enrolled another clinical trials within 1 month * Immunosuppression or autoimmune disease * Anticoagulant, general steroids within a week from surgery * Serious diseases (heart failure, renal failure, liver failure, uncontrolled hypertension, diabetes mellitus, coagulation deficiencies) * Patients with previous history of surgery at the same operate site
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| adhesion rate | 4 weeks after surgery | 4 weeks after surgery, finding adhesion using visceral slide test |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of adhesion symptoms | 4 weeks after surgery | 4 weeks after surgery, Identifying adhesion sysmptoms using Questionnaire |
| adverse event | 4 weeks after surgery | identifying adverse events after surgery |
Countries
South Korea